Trademarkia Logo

Australia

AU$
ROXAVII
Cancelled: Cancelled at the request of IB

Last updated on 7 Jun 2023

Owner Info

Biomarin Pharmaceutical Inc.

105 Digital Drive

Novato CA 94949, UNITED STATES OF AMERICA

Serial Number

2022243 filed on 4 Jun 2019

Correspondent

Gregory J. Chinlund Marshall Gerstein & Borun LLP

233 S. Wacker Drive,,

Suite 6300,

UNITED STATES OF AMERICA

ROXAVII

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of genetic diseases and disorders.

Mark Details


Serial Number

2022243

Registered On

4 Jun 2019

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

4 Dec 2018

Mark Type

US

Legal History


Show more

Status DateAction Taken
7th Jun 2023Status change to Voided
11th Jan 2020International Registration in Australia Protected correspondence sent
10th Jan 2020IP Right Registration Published
10th Jan 2020Status change to Registered/Protected
4th Nov 2019Application Accepted correspondence sent
3rd Nov 2019IP Right Acceptance Published
3rd Nov 2019IP Right has been Examined
3rd Nov 2019Status change to Accepted
11th Jul 2019Awaiting examination
11th Jul 2019Examination expedited